User profiles for Jennifer Vidler
Jennifer VidlerVerified email at nhs.net Cited by 1687 |
[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …
…, R Graham, J Cooper, M Khan, J Vidler… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…
Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5‐year experience
Delayed haemolytic transfusion reactions (DHTR) are potentially life‐threatening complications
in patients with sickle cell disease (SCD). Between 1 August 2008 and 31 December …
in patients with sickle cell disease (SCD). Between 1 August 2008 and 31 December …
[PDF][PDF] Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
…, T Ng, J Spicer, M Van Hemelrijck, M Kumar, J Vidler… - Cancer cell, 2021 - cell.com
Given the immune system's importance for cancer surveillance and treatment, we have
investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some …
investigated how it may be affected by SARS-CoV-2 infection of cancer patients. Across some …
[HTML][HTML] Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience
V Shah, TK Ko, M Zuckerman, J Vidler… - British Journal of …, 2020 - ncbi.nlm.nih.gov
2. Thachil J. What do monitoring platelet counts in COVID-19 teach us? J Thromb Haemost.
2020. https://doi. org/10.1111/jth. 14879 3. Pavord S, Thachil J, Hunt BJ, Murphy M, Lowe G, …
2020. https://doi. org/10.1111/jth. 14879 3. Pavord S, Thachil J, Hunt BJ, Murphy M, Lowe G, …
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …
…, R Graham, J Cooper, M Khan, J Vidler… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …
[PDF][PDF] Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
…, C Gousis, C Domingo-Vila, J Cooper, J Vidler… - Cancer Cell, 2021 - cell.com
Patients with cancer are considered to be at high-risk for SARS-CoV-2 infection and severe
COVID-19 (Bakouny et al., 2020). Our ‘‘SOAP-02’’(Sars-CoV-2 fOr cAncer Patients) study …
COVID-19 (Bakouny et al., 2020). Our ‘‘SOAP-02’’(Sars-CoV-2 fOr cAncer Patients) study …
[HTML][HTML] Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial
…, GK Dimitraidis, S Gogoi, J Vidler… - The Lancet …, 2023 - thelancet.com
Background From early in the COVID-19 pandemic, evidence suggested a role for cytokine
dysregulation and complement activation in severe disease. In the TACTIC-R trial, we …
dysregulation and complement activation in severe disease. In the TACTIC-R trial, we …
Treatment outcomes of complement protein C5 inhibition in 509 UK patients with paroxysmal nocturnal hemoglobinuria
RJ Kelly, M Holt, J Vidler, LM Arnold, J Large, B Forrest… - Blood, 2024 - ashpublications.org
Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal hematopoietic disorder
that occurs on a background of bone marrow failure (BMF). In PNH, chronic intravascular …
that occurs on a background of bone marrow failure (BMF). In PNH, chronic intravascular …
Venetoclax ramp‐up strategies for chronic lymphocytic leukaemia in the United Kingdom: a real world multicentre retrospective study
…, D Halperin, T Worth, J Vidler… - British Journal of …, 2023 - Wiley Online Library
This retrospective, observational study evaluated patterns of inpatient versus outpatient tumour
lysis syndrome (TLS) monitoring during venetoclax ramp‐up in 170 patients with chronic …
lysis syndrome (TLS) monitoring during venetoclax ramp‐up in 170 patients with chronic …
[HTML][HTML] Outpatient management of steroid-induced hyperglycaemia and steroid-induced diabetes in people with lymphoproliferative disorders treated with intermittent …
J Vidler, C Rogers, D Yallop, S Devereux… - Journal of clinical & …, 2017 - Elsevier
High dose steroids (HDS) are used in the treatment of haematological malignancies. The
reported risk of steroid-induced diabetes (SID) is high. However, screening is not consistently …
reported risk of steroid-induced diabetes (SID) is high. However, screening is not consistently …